Home - Products - Others - Other Targets - Lixisenatide

Lixisenatide

CAS No. 320367-13-3

Lixisenatide( —— )

Catalog No. M30039 CAS No. 320367-13-3

Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	162	Get Quote
5MG	214	Get Quote
10MG	365	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Lixisenatide
Note

Research use only, not for human use.
Brief Description

Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
Description

Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

GLP-1 receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

320367-13-3
Formula Weight

4858.49
Molecular Formula

C215H347N61O65S
Purity

>98% (HPLC)
Solubility

In Vitro:?H2O : 100 mg/mL (20.58 mM)
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Notoginsenoside S

Notoginsenoside S may have hepatoprotective effects.
Arenarioside

Arenarioside is a natural product and GI50 values of 10-16 microM against B16F10 cell.
Jagged-1 (188-204) T...

Jagged-1 (188-204) TFA is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-alphaB activation.

Sign In Join Free